Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0180
-0.0010 (-5.26%)
Oct 1, 2026, 4:10 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 69.55 million as of October 1, 2026. Its market cap has increased by 265.25% in one year.
Market Cap
69.55M
Enterprise Value
63.17M
Revenue
737.30K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has increased from 39.36M to 69.55M, an increase of 76.71%. That is a compound annual growth rate of 1.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 69.55M | 110.36% |
| Dec 31, 2025 | 33.06M | 317.27% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 108.01M |
| Recce Pharmaceuticals | 99.38M |
| Alterity Therapeutics | 88.83M |
| LTR Pharma | 87.25M |
| Prescient Therapeutics | 70.45M |
| Entropy Neurodynamics | 64.53M |
| Neurizon Therapeutics | 60.46M |
| Amplia Therapeutics | 59.03M |